Stay updated on RC48-ADC in HER2+ Biliary Cancer Clinical Trial
Sign up to get notified when there's something new on the RC48-ADC in HER2+ Biliary Cancer Clinical Trial page.

Latest updates to the RC48-ADC in HER2+ Biliary Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check21 days agoChange DetectedA banner announces NIH’s transition-related updates and says both “Super Intelligence” and “Artificial Intelligence” may appear across NIH content.SummaryDifference0.8%

- Check28 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site as revision v3.7.2 instead of v3.7.1. The study record content appears unchanged.SummaryDifference0.1%

- Check35 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check55 days agoChange DetectedA new revision entry v3.7.0 has been added to the study record history, and the previous revision v3.6.6 is removed from the list. This update reflects changes to the version history rather than to the core trial data.SummaryDifference0.1%

- Check77 days agoChange DetectedA new revision v3.6.6 has been added to the study record history, and the previous revision v3.6.5 has been removed, reflecting an update to the record since the last version.SummaryDifference0.1%

Stay in the know with updates to RC48-ADC in HER2+ Biliary Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RC48-ADC in HER2+ Biliary Cancer Clinical Trial page.